ClinicalTrials.gg
Sign In

Pituitary Neoplasms clinical trials

The registry lists 200 studies for Pituitary Neoplasms across more than 10 countries. 51 are recruiting or about to start. 135 of them are mainly about Pituitary Neoplasms (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 2 narrower conditions too, such as Prolactinoma: 217 studies, 57 open.

Get an email when these change. Save the Pituitary Neoplasms studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
76
Status unknown
39
Recruiting
36
Terminated
19
Active, not recruiting
10
Not yet recruiting
10

Phase

Phase 2
25
Phase 4
16
Phase 1
10
Phase 3
9
Early Phase 1
5

Where

United States
68
China
30
France
16
Italy
15
Germany
10
Canada
10

Who runs them

Novartis Pharmaceuticals (9) · Huashan Hospital (8) · St. Joseph's Hospital and Medical Center, Phoenix (6) · Peking Union Medical College Hospital (6) · National Institute of Neurological Disorders and Stroke (NINDS) (5) · Federico II University (5) · Columbia University (4) · Mayo Clinic (4)

What is being tested here

Drugs under test in Pituitary Neoplasms studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Cabergoline126
Gallium-68101
Panitumumab101
IRDye800101
Deamino Arginine Vasopressin101
Cefdinir101
Pasireotide028
Temozolomide013
Dexmedetomidine003
Sevoflurane002

Drug classes tested here Inhaled anesthetics 3

Coming up

2phase 3 studies under way
13studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 36 Pituitary Neoplasms studies recruiting now, 14 (39%) set no upper age limit and 10 (28%) stop at 75 or younger. 6 (17%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 4 (11%) take healthy volunteers.

Recruiting studies that take each age, of 36
AgeWomenMen
105 (14%)5 (14%)
1833 (92%)33 (92%)
3036 (100%)36 (100%)
4036 (100%)36 (100%)
5036 (100%)36 (100%)
6536 (100%)36 (100%)
7532 (89%)32 (89%)
8522 (61%)22 (61%)

Across all 200 studies, recruiting or not: 24% stop at 75 or younger and 10% at 65; 17% take children; 1% are for women only and 1% for men only; 11% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Pituitary Neoplasms studies take

Of 46 interventional studies with no phase under Pituitary Neoplasms, half reached primary completion within 48 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase48 mo16–68 · 46 studies——
Observational163 mo32–349 · 33 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 200. Browse all 200 → or search them.